Related Experiment Video

Updated: Jul 17, 2026

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
07:30

A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

Published on: November 9, 2017

Evolution and treatment of childhood chronic inflammatory polyneuropathy

Elsa Rossignol1, Guy D'Anjou, Normand Lapointe

  • 1Service de neurologie, Département de pédiatrie, Centre hospitalier universitaire Sainte-Justine, Montréal, Québec, Canada.

Pediatric Neurology
|February 6, 2007
PubMed

Insights

Chronic inflammatory demyelinating polyneuropathy (CIDP) in children is rare but often treatable. This study reviews 13 pediatric cases, including refractory instances, to inform treatment strategies.

Area of Science:

  • Pediatric Neurology
  • Clinical Case Series
  • Rare Diseases

Background:

  • Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune disorder affecting peripheral nerves.
  • Pediatric CIDP typically responds to standard immunomodulatory therapies.
  • A subset of pediatric CIDP cases exhibit resistance to conventional treatments.

Purpose of the Study:

  • To describe the clinical course and treatment outcomes of pediatric CIDP patients.
  • To review the literature on managing refractory CIDP in pediatric populations.
  • To identify potential therapeutic approaches for treatment-resistant pediatric CIDP.

Main Methods:

  • Retrospective review of 13 pediatric CIDP patients treated between 1975 and 2005.
  • Inclusion of two recent cases with refractory disease.
  • Comprehensive literature search on refractory CIDP treatments in children and adults.

Main Results:

  • Most pediatric CIDP cases responded to standard therapies (immunoglobulins, corticosteroids, plasmapheresis).
  • Two recent cases presented with refractory disease, highlighting treatment challenges.
  • Literature review provided insights into alternative and advanced treatment options.

Conclusions:

  • While most pediatric CIDP cases are manageable, refractory disease necessitates exploring alternative therapies.
  • Understanding treatment responses in both pediatric and adult refractory CIDP is crucial.
  • Further research is needed to establish optimal treatment guidelines for refractory pediatric CIDP.

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...